ArticleCell communication and signaling : CCS2025

A proteogenomic gene signature defines prognostic subgroups highlighting PI3K/AKT/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies.

Fan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.